ClinVar Miner

Submissions for variant NM_000090.4(COL3A1):c.3077G>C (p.Gly1026Ala)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
All of Us Research Program, National Institutes of Health RCV004015823 SCV004839091 likely pathogenic Ehlers-Danlos syndrome, type 4 2024-01-08 criteria provided, single submitter clinical testing This missense variant replaces glycine with alanine at codon 1026 of the COL3A1 protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function. This variant changes one of the conserved glycine residues within the Gly-Xaa-Yaa repeats of the triple helix domain that are required for the structure and stability of fibrillar collagens (PMID: 7695699, 8218237, 19344236). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with COL3A1-related disorders in the literature. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Based on the available evidence, this variant is classified as Likely Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.